Chanita Hughes-Halbert to Breast Neoplasms
This is a "connection" page, showing publications Chanita Hughes-Halbert has written about Breast Neoplasms.
Connection Strength
2.594
-
Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women's concerns? J Clin Oncol. 2011 Nov 10; 29(32):4302-6.
Score: 0.193
-
Effect of genetic counseling and testing for BRCA1 and BRCA2 mutations in African American women: a randomized trial. Public Health Genomics. 2010; 13(7-8):440-8.
Score: 0.173
-
Utilization of religious coping strategies among African American women at increased risk for hereditary breast and ovarian cancer. Fam Community Health. 2009 Jul-Sep; 32(3):218-27.
Score: 0.164
-
BRCA1 and BRCA2 risk perceptions among African American women at increased risk for hereditary breast-ovarian cancer. Community Genet. 2008; 11(4):193-200.
Score: 0.151
-
Experiences with weight change in African-American breast cancer survivors. Breast J. 2008 Mar-Apr; 14(2):182-7.
Score: 0.149
-
Retention of African American women in cancer genetics research. Am J Med Genet A. 2008 Jan 15; 146A(2):166-73.
Score: 0.149
-
Sociocultural predictors of breast cancer risk perceptions in African American breast cancer survivors. Cancer Epidemiol Biomarkers Prev. 2007 Feb; 16(2):244-8.
Score: 0.139
-
Low rates of acceptance of BRCA1 and BRCA2 test results among African American women at increased risk for hereditary breast-ovarian cancer. Genet Med. 2006 Sep; 8(9):576-82.
Score: 0.135
-
Breast cancer screening behaviors among African American women with a strong family history of breast cancer. Prev Med. 2006 Nov; 43(5):385-8.
Score: 0.134
-
Perceptions of changes in weight among African American breast cancer survivors. Psychooncology. 2006 Feb; 15(2):174-9.
Score: 0.130
-
Recruiting African American women to participate in hereditary breast cancer research. J Clin Oncol. 2005 Nov 01; 23(31):7967-73.
Score: 0.128
-
Attitudes about genetic testing and genetic testing intentions in African American women at increased risk for hereditary breast cancer. Genet Med. 2005 Apr; 7(4):230-8.
Score: 0.122
-
Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations. J Behav Med. 2004 Aug; 27(4):373-92.
Score: 0.117
-
Decisions and outcomes of genetic testing for inherited breast cancer risk. Ann Oncol. 2004; 15 Suppl 1:I35-I39.
Score: 0.112
-
Racial Disparities and Diagnosis-to-Treatment Time Among Patients Diagnosed with Breast Cancer in South Carolina. J Racial Ethn Health Disparities. 2022 02; 9(1):124-134.
Score: 0.091
-
The big reveal: Family disclosure patterns of BRCA genetic test results among young Black women with invasive breast cancer. J Genet Couns. 2020 06; 29(3):410-422.
Score: 0.085
-
Impact of Genetic Testing on Risk-Management Behavior of Black Breast Cancer Survivors: A Longitudinal, Observational Study. Ann Surg Oncol. 2020 May; 27(5):1659-1670.
Score: 0.084
-
Acceptance of a community-based navigator program for cancer control among urban African Americans. Health Educ Res. 2014 Feb; 29(1):97-108.
Score: 0.055
-
Low rates of African American participation in genetic counseling and testing for BRCA1/2 mutations: racial disparities or just a difference? J Genet Couns. 2012 Oct; 21(5):676-83.
Score: 0.051
-
Predictors of yoga use among patients with breast cancer. Explore (NY). 2010 Nov-Dec; 6(6):359-63.
Score: 0.045
-
Genetic counseling and testing for breast cancer risk in African Americans. LDI Issue Brief. 2006 Sep; 12(1):1-4.
Score: 0.034
-
Satisfaction with genetic counseling for BRCA1 and BRCA2 mutations among African American women. Patient Educ Couns. 2006 Oct; 63(1-2):196-204.
Score: 0.033
-
Psychological functioning in African American women at an increased risk of hereditary breast and ovarian cancer. Clin Genet. 2005 Sep; 68(3):222-7.
Score: 0.032
-
Utilization of BRCA1/BRCA2 mutation testing in newly diagnosed breast cancer patients. Cancer Epidemiol Biomarkers Prev. 2005 Apr; 14(4):1003-7.
Score: 0.031
-
Predictors of participation in psychosocial telephone counseling following genetic testing for BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev. 2004 May; 13(5):875-81.
Score: 0.029
-
Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol. 2004 May 15; 22(10):1823-9.
Score: 0.029